Introduction
============

Cancer is one of the greatest conundrums in the modern medical field, posing a great threat to human health [@B1]-[@B3]. Conventional cancer therapies include surgery [@B4], chemotherapy [@B5], and radiotherapy [@B6], which have pros and cons. Surgery fails to completely remove all tumor tissues, resulting in a high recurrence rate [@B7]. Chemotherapy usually lacks selectivity to cancer cells and typically causes multi-drug resistance [@B8]. Radiotherapy can damage healthy cells and tissues near cancer cells [@B9]. Thus, existing cancer treatment options have limited therapeutic effects. Recently, new treatment modalities with improved efficacy and reduced adverse effects have received much attention, especially phototherapy dating back to three thousand years. The treatment of lupus vulgaris with a short-wavelength light by Niels Ryberg Finsen was awarded the Nobel Prize in 1903, instigating the development of phototherapy [@B10], which is a minimally invasive, controllable technique that relies on the phototherapeutic agents in conjunction with light irradiation to kill cancer cells selectively [@B11]-[@B13]. As two typical phototherapy approaches, photodynamic therapy (PDT) and photothermal therapy (PTT) have been extensively studied and are commonly used. PTT agents absorb a selective wavelength of light and dissipate the absorbed energy through non-radiative decay that increases the temperature in the local environment, leading to the thermal ablation of cancer cells [@B14], [@B15]. However, in the actual treatment process, excessive heat tends to damage normal cells and tissues, causing complications and negatively affecting the treatment.

Despite its shortcomings, PDT has become a promising therapeutic option by using photosensitizers (PS) and light irradiation to induce cell death and tissue destruction [@B16]. Upon exposure to appropriate wavelength light, the PS can transfer energy to surrounding oxygen molecules and produce cytotoxic reactive oxygen species (ROS), such as singlet oxygen (^1^O~2~), superoxide, hydrogen peroxide (H~2~O~2~), and hydroxyl radicals, which efficiently eliminate highly proliferating cells by severe and irreversible damage to their organelle [@B17], [@B18]. PDT has been extensively studied in the treatment of both premalignant and malignant skin tumors [@B19], [@B20], head [@B21] and neck [@B22], [@B23], prostate [@B24], [@B25], non-small-cell lung [@B26], [@B27], and other cancers. Due to the high cytotoxicity of the generated ^1^O~2~, PDT can generate much greater treatment effects than PTT. Compared to the widely used chemotherapy and radiotherapy, PDT entails beneficial features like reduced side effects on normal tissues, possible repeatable doses, and absence of scarring [@B28], [@B29]. Considering these merits, PDT has been under the research spotlight for in-depth investigation as an important paradigm for a variety of cancers and non-cancerous lesions in recent years.

Despite considerable progress in its use for cancer treatment, a few outstanding issues for the efficacy of PDT include PS utilization efficiency, light penetration depth, and endogenous oxygen generation in tumors [@B30]-[@B32]. The hypoxia in tumor tissues, caused by the abnormal vasculature perfusion, uncontrollable cell proliferation, and dysfunctional lymphatic system, significantly impairs the PDT outcome [@B33], [@B34]. Conversely, PDT aggravates the hypoxia in the tumor microenvironment because of oxygen depletion and the vascular shutdown effect, finally triggering tumor metastasis and tumor recurrence [@B35], [@B36]. Besides, the antioxidative glutathione (GSH) overexpressed in cancer cells can scavenge the generated ROS, thus lowering PDT efficacy. To address these issues and deliver the PS molecules to the desired site, several new approaches have been considered for maximizing the efficacy of PDT. The integration of nanotechnology with material science has led to the extensive application of nanoplatforms in medicine [@B37]-[@B39], especially nanoplatform-based drug delivery systems. These systems show diagnostic and therapeutic prospects in clinical applications due to the localization ability, high-efficiency, low-toxicity, and controlled release of drugs [@B40], [@B41]. More specifically, PDT, combined with nanosystems has become a hot spot in the prevention, diagnosis, treatment, and monitoring of tumors. Such nanoplatforms are elaborately constructed to achieve enhanced PDT for specific targeting, high drug loading, and multi-functional integration [@B42]-[@B44].

This review aims to provide an overview of nanotherapeutic advancements for enhanced PDT targeted towards tumor therapy in the last five years (Figure [1](#F1){ref-type="fig"}). We categorize functional polymer nanoplatforms to achieve specific accumulation of PS in tumors to enhance PDT, such as targeting performance, responsive release, and charge turnover. High-efficiency PDT of self-oxygenation systems (carrying oxygen and generating oxygen) and photocatalytic hybrid nanoplatforms are summarized. Also, enhanced PDT with nanoplatforms using X-rays, plasmon resonance and other physical methods have been outlined. Finally, we highlight the challenges and possible developments of nanoplatforms for enhanced PDT, which could inspire the design of nanoplatforms and prompt clinical applications of PDT in tumor therapy.

Targeted and responsive nanoplatforms for enhanced PDT
======================================================

Targeting nanoplatforms
-----------------------

When the nanoplatforms are injected into the biological tissue, they are often recognized as intruders by the immune system, provoking an immune response [@B45]. Also, the nanoplatforms are likely to be picked up and cleared out by the mononuclear phagocyte system during blood circulation, leading to shortened circulation time and limited therapeutic effects [@B46]. The nontargeting nanoplatforms can passively target the tumor through enhanced permeability and retention (EPR) effect and, therefore, can deliver a small amount of nanomedicine to the tumor sites. On the other hand, nanoplatforms endowed with targeting ability can achieve specific and improved delivery to tumor tissues. Another important aspect of PDT is that the PS is taken up by different subcellular organelles such as the mitochondria, lysosomes, endoplasmic reticulum, Golgi apparatus, and plasma membranes [@B47], [@B48] and under light irradiation, its subcellular localization largely determines the damage produced by ROS. Thus, it would be of great interest to exploit targeted nanoplatform delivery systems to transport PS directly into the desired subcellular organelles [@B49].

**Cell membrane** is the most important protective barrier in living cells maintaining cell integrity and guarantees the essential cellular functions [@B50], [@B51]. Severe damage to the plasma membrane induces cellular apoptosis, necrosis, and autophagy. Cell membrane-targeted therapy can be more efficient because it does not require endocytosis of drugs. Moreover, many shortcomings of conventional chemotherapy, such as the intracellular degradation of drugs or drug resistance-induced failures, can be avoided [@B52]. A novel charge reversible self-delivery chimeric peptide C~16~-PRP-DMA (C~16~-K(PpIX)RRK(DMA)K(DMA)-PEG-COOH) was designed for long-term cell membrane**-**targeted PDT (Figure [2](#F2){ref-type="fig"}A). The self-assembled nanoparticles could stay on the cancer cell membrane for a long time because of the synergetic effect of alkyl chain palmitic acid and positively charged RRKK attached to the cell membrane [@B53]. Under light irradiation, the ROS generated by the inserted C~16~-PRP-DMA directly disrupted the cell membrane and rapidly caused cell necrosis, remarkably increasing the PDT effect *in vitro* and *in vivo*. To maximize the therapeutic potency, a self-transformable pH-driven, membrane-anchoring nanoplatform was constructed by attaching protoporphyrin IX (PpIX) to the end of the water-soluble peptide [@B54]. Benefiting from the insertion peptide, the nanoplatform could form an α-helix structure under acidic conditions (pH 6.5 or 5.5), but remained random coil at normal pH of 7.4. This feature enabled successful insertion of nanoplatforms into the membrane lipid bilayer, especially for cancerous cell membranes in the acidic tumor microenvironment. Under laser irradiation at 630 nm, the plasma membrane was severely damaged by in situ generated ROS, subsequently inducing cell death [@B54]. In particular, *in vivo* studies indicated the high inhibition effect of this nanoplatform against primary tumors and the successful prevention of tumor metastasis.

**Nucleus** is the most significant organelle in the cell and contains most of the intracellular genetic materials [@B55]. Any disruptions inside the nucleus would subsequently affect the cellular DNA disturbing the highly regulated cell cycle. Consequently, nuclear-targeted strategies could facilitate the penetration of the PS into the nucleus and greatly improve therapeutic efficiency. As shown in Figure [2](#F2){ref-type="fig"}B, Shi\'s group *et al.* made TAT and RGD peptides co-conjugated with mesoporous silica nanoparticles (MSNs) as PDT carriers [@B56]. TAT peptides enabled the nuclear penetration of mesoporous silica nanoparticles for efficient accumulation of the PS inside the nuclei. Upon irradiation, the intranuclearly accumulated PS could generate ROS to destroy DNA instantaneously. Moreover, the co-conjugated RGD peptides endowed the nuclear-targeted delivery system with recognition of and specific binding to tumor vasculature and tumor cell membranes for significantly enhanced specificity and reduced side effects. As is evident from Figures [2](#F2){ref-type="fig"}B2 and 2B3, the nuclear-targeted nanoplatforms exerted substantially stronger inhibition effect on tumor growth than Ce6\@MSNs-RGD, Ce6\@MSNs, and free Ce6. Taking advantage of structural programmability and biocompatibility, self-assembled DNA nanostructures have attracted much attention in biomedical applications. Yang *et al.* developed nanoscale coordination polymers (NCPs) based on the interaction between calcium ions (Ca^2+^) and AS1411 DNA G quadruplexes [@B57]. Both Ce6 and an iron-containing porphyrin inserted into the G-quadruplex structure. The NCPs enabled the intranuclear transport of Ce6 to generate ROS inside cell nuclei. AS1411 inhibited the expression of antiapoptotic protein B-cell lymphoma 2 (Bcl-2), allowing for greatly improved PDT-induced cell apoptosis. Furthermore, the catalase-mimicking DNA enzyme function of G-quadruplexes and hemin could react with tumor endogenous H~2~O~2~ to generate oxygen for enhanced PDT by overcoming the hypoxia-associated resistance.

**Mitochondria** is the primary source of cellular ROS production (approximately up to 90%), which plays vital roles in energy production and cell apoptosis [@B58], [@B59]. Moreover, mitochondria could be susceptible to excessive ROS. The initial formation of ROS-induced changes in mitochondrial permeability, depolarization, deformation, and release of cytochrome C, ultimately resulted in apoptosis [@B60], [@B61]. Therefore, a PS delivery system targeting mitochondria is greatly beneficial for enhancing the photodynamic therapeutic effect. The peptide Ad-CGKRK-GFLG-EE-HAIYPRH(T7) with a guest molecule Ad termination and cathepsin B (CTSB) (overexpressed in cancer cells)-cleavable linker GFLG was developed, and Ce6 was conjugated to the host molecule b-Cyclodextrin (b-CD) through an amide bond. Through CD/Ad recognition, CD-Ce6 and Ad-CGKRK-GFLG-EE-HAIYPRH (T7) inclusion complexation self-assembled into supramolecular nanoplatforms [@B62]. T7 modification endowed supramolecular nanoplatforms with targeting ability for MCF-7 cancer cells. After internalization, the cleavage of the GFLG sequence by overexpressed CTSB exposed the mitochondria-targeting peptide CGKRK allowing the accumulation of nanocarriers in mitochondria and enhancing the PDT effect. Another mitochondria and plasma membrane dual-targeting nanoplatform was developed using the chimeric peptide for single-agent synergistic PDT [@B63], which included a hydrophobic photosensitizer PpIX, a bioactive peptide sequence with dual targeting function, and a hydrophilic poly (ethylene glycol) (PEG) chain. This amphipathic chimeric peptide could form spherical micelles by self-assembly in aqueous solution, with high drug loading efficacy as well as the excellent ability to produce ROS. Plasma membrane-targeting PDT increased the membrane permeability to improve the cellular delivery of nanoplatforms, and even directly disrupted the cell membrane to induce cell necrosis. Additionally, mitochondria-targeted PDT reduced mitochondrial membrane potential and significantly promoted cell apoptosis. Consequently, the dual-targeting property facilitated the effective subcellular localization of PpIX to generate ROS for enhanced PDT.

**Lysosomes** are important subcellular acidic organelles for cellular homeostasis, whose dysfunction is responsible for several diseases [@B64]. There is ample evidence to verify that the lysosomal death pathway could contribute to the programmed cell death sensitivity of cancer cells [@B65]. Xiang *et al.* developed novel cancer cell lysosome-targetable NO-delivery nanoplatforms composed of a ruthenium nitrosyl donor (Lyso-Ru-NO), a cancer cell directing group of folic acid, and a carrier of biocompatible carbon-doped titanium dioxide nanoparticles (Figure [2](#F2){ref-type="fig"}C) [@B66]. The ruthenium nitrosyl Lyso-Ru-NO group contained the Lyso-NINO ligand, wherein a morpholine moiety targeted the lysosomes. The incorporation of folic acid and morpholine groups rendered it capable of targeting folate-receptor overexpressing-cancer cells and specifically accumulating in the subcellular lysosomal organelles, where 808 nm NIR light irradiation simultaneously released NO and ROS. The cytotoxicity assay showed that the dual-targeted nanoplatforms have the highest anticancer efficacy compared to their nontargeted counterparts under NIR light sensitization. To further compare differences in mitochondria- and lysosome-targeted PDT, two PS were designed based on iridium (III) complex (Ir-P(ph)~3~ and Ir-alkyl group, which specifically targeted the mitochondria and lysosomes, respectively. The results indicated that HeLa cells treated with the mitochondria-targeted complex kept a slower respiration rate, resulting in a higher intracellular oxygen level under hypoxia. Consequently, this complex showed an enhanced PDT effect compared to the lysosome-targeted complex, especially under hypoxic conditions [@B67]. It is possible that the mitochondria-targeted PS inhibited mitochondrial respiration, leading to higher intramitochondrial oxygen content, and, therefore, is more beneficial for PDT in hypoxic tumor cells.

Apart from organelle-targeting nanoplatforms, other nanoplatforms can also achieve enhanced PDT. Macrophages are highly abundant in the stroma of solid tumors and have been demonstrated to play an important role in the development and progression of cancer [@B68]. Moreover, macrophages can enrich much more PS than tumor cells, making the PDT effect greatly potentiated when the tumors are treated with PS with a macrophage-activating factor. C-Phycocyanin, a macrophage-targeting agent, has been widely used in food, cosmetics, and biomedical applications due to its good biocompatibility, non-toxicity, water-solubility, unique color, strong absorption in the visible region (550-650 nm), and high fluorescence quantum yield. When combined with unsubstituted zinc phthalocyanine, it could facilitate PS for PDT. Furthermore, this conjugation exhibited an enhanced photodynamic effect due to the improved solubility and aggregation of zinc phthalocyanine [@B69]. Thus, C-Phycocyanin can act as both a new class of tumor-associated macrophages PS and a desirable nanoplatform for other therapeutic agents. Besides, lactoferrin is a member of the transferrin family and commonly found in blood plasma, and has a potential role in treating diseases because of its antioxidant, antitumor, antiviral, and antifungal properties. Adimoolam *et al.* loaded Ce6 into lactoferrin by the water-in-oil emulsion method [@B70]. The yield of reactive oxygen was enhanced in the nanoplatforms compared to free Ce6. Also, specific Ce6 release at low pH and higher uptake and intracellular concentrations of Ce6 compared with free Ce6*in vitro* were observed. Upon exposure to light, the nanoplatforms caused light-mediated cell death in the SK-OV-3 and MDA-MD 231 cells. Compared to free Ce6, it showed a substantial decrease (44 times) in the Ce6 requirement.

Despite significant advancements, targeted therapeutic agents are still limited to clinical applications. The development of malignant tumors is an extremely complicated process. It involves multiple genes and new gene mutations evolve in a multistep process, increasing the difficulty of targeted therapy. Targeted tumor agents show considerable toxicity to the digestive tract and vasculature with a negative impact on the therapeutic effect. To overcome the defects in targeted therapy, the joint application of various targeted drugs might show a better outcome.

Responsive nanoplatforms for enhanced PDT
-----------------------------------------

Efficient cellular internalization of the nanoplatforms and on-demand release of the PS are two significant steps for efficacy enhancement [@B71], [@B72]. A high degree of cellular uptake can guarantee the maximal amount of intracellular PS, whereas rapid cargo release can address the problem from the limited diffusion distance as well as the short half-life of ^1^O~2~. It is vital to design responsive nanoplatforms to enhance cellular uptake and control PS release. So far, exogenous (externally applied) stimuli to trigger PS release, such as temperature [@B73], [@B74], light [@B75], [@B76], and magnetic triggers [@B77], [@B78], have been explored widely. Besides, tumor pathophysiology displays characteristic changes such as pH [@B79], enzyme activity [@B80], or redox properties [@B81], and allowing opportunities to exploit these endogenous factors as internal stimuli. Table [1](#T1){ref-type="table"} summarizes targeted and responsive nanoplatforms for enhanced PDT.

### Tumor microenvironment (pH and GSH)-responsive nanoplatforms

The microenvironment of cancerous tissues is specific and markedly different from that of the extracellular matrix and normal tissues. pH is one of the stimuli that has been most frequently utilized to control intracellular drug delivery in specific organs based on environmental changes induced by pathological conditions [@B82], [@B83]. Furthermore, the pH difference can be found in some organelles, such as endosomes (pH lower than 4.5) and lysosomes (\~pH 5.5), where it is much lower than other intracellular organelles [@B84], [@B85]. Due to the pH gradient between the tumor microenvironment (pH ≈ 6.5) and the physiological environment (pH ≈ 7.4), the pH-responsive nanoplatforms undergo conformational changes through various mechanisms, such as protonation [@B86], charge reversal, or cleavage of a chemical bond [@B87], facilitating tumor-specific cell uptake or drug release. Such responsive nanoplatforms are usually fabricated through physically encapsulating or chemically conjugating the PS. So far, a variety of pH-responsive nanoplatforms have been designed to exploit low extracellular pH~ex~ or endosomal pH~en~. For example, Tong *et al* attached 5-aminolevulinic acid (ALA) to a-cyclodextrin (a-CD) through an acid-labile hydrazone bond. Subsequently, the pH-responsive, cell-penetrating peptide R6H4 (RRRRRRHHHH) was conjugated to PEG to form PEG-R6H4. As shown in Figure [3](#F3){ref-type="fig"}A, dual pH-responsive ALA pseudopolyrotaxane prodrug micelles were developed by the host-guest interaction of a-CD and PEG. Taking advantage of the pH-responsive R6H4, the nanoplatforms were easily internalized into tumor cells. Furthermore, ALA was released by the cleavage of the hydrazone bond at endo/lysosomal pH and further converted to PpIX for enhanced PDT [@B88]. To achieve multifunctionality, Chu *et al* used pH-responsive copolymers poly(ethylene glycol) methacrylateco-2-(diisopropylamino)ethyl methacrylate, biodegradable copolymers methoxypoly(ethyleneglycol)/poly(ε-caprolactone), and maleimide-modified biodegradable copolymers to prepare new micelles. After entrapping the photosensitizer Ce6, the micelles were coated with the epidermal growth factor receptor (EGFR)-targeting peptide GE11, and showed enhanced PDT efficacy [@B89]. This could be attributed to the increased Ce6 uptake due to GE11 targeting and increased release of Ce6 for improved elimination of cancer cells in the acidic tumor microenvironment.

Recently, pH-dependent charge reversal delivery nanoplatforms exhibited great superiority in controlled release and targeted drug delivery [@B90]. The surface charge of nanoplatforms plays a decisive role in cell internalization and blood stability. The nanoplatforms can keep their original negatively charged status under neutral conditions in the bloodstream, thus preventing nonspecific interactions with serum proteins and normal tissues [@B91]. Upon arriving at the tumor tissues or endo/lysosomes, the original negative charge can quickly convert into positively charged status, thus triggering the efficient cell internalization. For example, tumor pH-sensitive photodynamic nanoplatforms NaYF~4~:Yb,Er\@CaF~2,~ were comprised of self-assembled, PS-grafted, pH-responsive polymeric ligands [@B92], which were prepared by derivatizing poly(ethylene glycol)-poly(β-benzyl-l-aspartate) with 1-(3-aminopropyl) imidazole, 3-phenyl-1-propylamine, and Ce6. The nanoplatforms were negatively charged without any discernible photoactivity at normal blood pH of ≈7.4 but quickly switched their surface charge from negative to positive at an extracellular tumor pH of ≈6.5. These nanoparticles not only exhibited enhanced tumor-cell internalization due to charge reversal but disassembled into well-dispersed nanoparticles in the endo/lysosomes of tumor cells, thus enabling efficient PDT. Besides, charge-reversal phthalocyanine-based coordination polymer nanoplatforms (PCPNs\@Lip/DLC) were developed to improve the curative effect of PDT [@B93]. Tetra(4-carboxyphenoxy)-phthalocyaninatozinc coordinated with zinc was coated with a self-assembled lipid bilayer (Figure [3](#F3){ref-type="fig"}B), and 1,2-dicarboxylic-cyclohexane anhydride-modified lysyl-cholesterol (DLC) was functionalized on the surface of PCPN, endowing it with a charge-reversal ability. When exposed to a mildly acidic environment in the tumor tissue, DLC could degrade and enabled increased tumor uptake of PCPN due to the electrostatic interaction with the negatively charged cell membrane. The nanoplatforms were verified to enhance tumor cellular uptake and generate increased intracellular ROS after irradiation. As confirmed by *in vitro* and *in vivo* studies, the nanoplatforms remarkably increased the PDT effect. Despite the obvious potential of pH-sensitive nanoplatforms, they sometimes need to be combined with other stimuli to achieve precise and specific drug release at the targeted tumor sites.

Besides the difference in pH environment, the intracellular glutathione (GSH) level of cancer cells has been widely reported to be considerably higher (about 10 mM) than that in the extracellular matrix (about 2 μM) [@B94], [@B95]. GSH can be used as a reducing agent due to the thiol groups and is an important antioxidant that can prevent the damage to the cellular components induced by ROS [@B96]. Previous reports have indicated that high intracellular GSH levels in tumor cells can effectively trigger drug release [@B97], [@B98], facilitating efficient PS uptake from the functional nanoplatforms. Disulfide, selenium, or tellurium-containing nanoplatforms were exploited as redox-responsive drug-delivery systems [@B99], [@B100]. Zhang*et al.* developed supramolecular host-guest complexation between a PEG-functionalized pillararene and a pyridinium-terminated porphyrin derivative-bearing disulfide bond [@B5]. The supramolecules could self-assemble into spherical micelles with good colloidal stability, which exhibited the rapid release of porphyrin PS in a reducing environment. *In vitro* cytotoxicity confirmed that the supramolecular amphiphiles exhibited superior cellular uptake and remarkably enhanced PDT [@B101]. Another biocompatible stimuli-activated photosensitive nanoplatform (PEG-TPP-DNB) based on porphyrin molecules was designed (Figure [4](#F4){ref-type="fig"}A1). 5,15-bis(4-aminophenyl)-10,20-diphenylporphyrin was regarded as the center of molecular structure and further modified at both ends with PEG chain and the functional group 2,4-dinitrobenzene via pH-deionized and thiol-labile sulfonamide linkages. Because nitrobenzene has a strong ability to withdraw electrons on the porphyrin macrocycles, the nanoplatforms remarkably quenched the fluorescence and ^1^O~2~. Therefore, the redox-sensitive and activated nanoplatforms could minimize the biological imaging background and phototoxicity to normal tissues. In aqueous media, the amphiphilic nanoplatforms could self-assemble into nanomicelles and dissociate in response to the reductive thiol such as GSH. *In vivo* bioimaging further elucidated that the micelles showed selective tumor imaging and targeted PDT antitumor effect as well as low systemic toxicity (Figure [4](#F4){ref-type="fig"}A2). Overall, the amphiphilic nanoplatforms not only afforded targeted release of PS for maximized tumor enrichment but also exhibited excellent tumor-targeting PDT efficacy [@B102].

Although GSH stimulates the responsive nanoplatforms to release PS for enhanced PDT, the high concentration of GSH decreases ROS generation in cells, reducing the effectiveness of PDT. It has been demonstrated that a decrease in GSH concentration in tumor tissues could promote the ROS level by using nanoplatforms [@B103], [@B104]. A nano-metal-organic framework (MOF) was designed to enhance PDT. Cu^II^ as the active center of MOF could specifically bind and absorb GSH, thus directly reducing the intracellular GSH concentration and increasing the ROS level. Simultaneously, the porphyrin ligand could be used as the PS to generate abundant ROS under light irradiation. *In vitro* experiments indicated that MOF was readily taken up by breast cancer cells, and high ROS levels were produced under light irradiation. This synergistically-increased ROS concentration accelerated apoptosis, enhancing the effect of PDT [@B105]. Using a similar enhancement mechanism, Zeng *et al.* incorporated a p-phenylboronic ester (PB) into the clinical PS methylene blue with a carbonochloridate PB-Cl, and encapsulated them within BSA to achieve imaging-guided tumor-targeted effective PDT (Figure [4](#F4){ref-type="fig"}B1). In the presence of H~2~O~2~, the resultant caged nanoplatforms underwent H~2~O~2~-mediated boronic ester oxidation, releasing the hydrophilic methylene blue to produce ^1^O~2~, and quinoned methide rapidly deactivated GSH boosting the ^1^O~2~ yield, thus synergistically strengthening the efficacy of PDT. Furthermore, the BSA-MBPB nanoplatforms could also recover the fluorescent and photoacoustic dual-modal imaging of the tumor region and precisely guide the tumor-selective PDT [@B106] (Figure [4](#F4){ref-type="fig"}B2 and 4B3).

### Enzyme-responsive nanoplatforms

Enzyme-responsive nanoplatforms have been increasingly utilized for PDT because they could selectively and efficiently involve in all physiological, metabolic, and pathological processes [@B107]. Several studies have shown that hyaluronidase (HAase) enables the degradation of extracellular matrix to enhance therapies by increasing intratumor penetration of the drugs, and modulates the hypoxic tumor microenvironment [@B108]. A smart hyaluronidase-activated theranostic nanoplatform was prepared based on hyaluronic acid (HA) coupled with Ce6 using adipic dihydrazide (ADH). This nanoplatform could be specifically degraded and released by hyaluronidase in the tumor, exhibiting higher fluorescence and photoacoustic intensity than free Ce6. Additionally, this HA-based nanoplatform showed more effective PDT than free Ce6 to suppress tumor growth *in vitro* and *in vivo* [@B109]. Besides, the NQO1-based nanoplatforms also generated increasing attention as NQO1 is upregulated (\~2-50-fold) in breast, pancreatic, colorectal, cervical, and lung cancers [@B110]. Yao and co-workers developed self-assembled vesicles from amphiphilic block copolymers containing quinone trimethyl lock-capped self-immolative side linkages and quinone-bridged Nile blue in the hydrophobic block [@B111]. Initially, their fluorescence emission and PDT potency were in the "off" state due to dye aggregation-caused quenching and quinone-rendered photoinduced electron transfer quenching. After internalization into NQO1-positive vesicles, the cytosolic NQO1 enzyme triggered the cleavage of quinone linkages and fluorogenic release of conjugated PS, resulting in NIR fluorescence emission turn-on and enhanced PDT.

### ROS-responsive nanoplatforms

ROS plays a vital role in the physiological and pathophysiological processes of the human body [@B112]. It is also essential for the growth, development, and adaptation of organisms. In normal conditions, low concentrations of ROS regulate cell-signaling pathways and promote cell proliferation, whereas high levels of ROS induce oxidative stress that can disrupt the steady-state of cells and damage cellular components including membrane lipids, proteins, DNA, and other biological molecules [@B113], [@B114]. Therefore, a lack of ROS or an excess of ROS may induce several abnormalities, including autoimmune, cardiovascular, and neurodegenerative diseases [@B115], [@B116]. This abnormal biochemical alteration in the disease sites has inspired studies on unbalanced ROS levels for developing target-specific drug delivery systems. By utilizing ROS-responsive materials and linkers, various ROS-responsive drug delivery systems have been developed for therapeutic purposes. ^1^O~2~-responsive nanoplatforms are particularly appealing because of the highly reactive nature of ^1^O~2~ and the rapid onset of responsive cascade events. Guruswamy *et al.* designed a novel biocompatible visible-light-responsive amphiphilic poly(ethylene glycol)-block-poly(caprolactone)copolymer by incorporating an ^1^O~2~-sensitive vinyldithioether linker between the hydrophilic segments and the hydrophobic block [@B117]. The amphiphilic micelles could disassemble the nanostructure due to ^1^O~2~ generated by visible light, and further release Ce6 and anticancer drug doxorubicin (DOX) for enhanced PDT. To further regulate the release of PS for improved PDT, Li *et al.* developed a methoxy poly(ethylene glycol)-azobenzene-poly(aspartic acid) copolymer conjugated with imidazole as the side chains [@B118]. The azobenzene and imidazole are hypoxia- and singlet oxygen-responsive (SR) moieties, respectively. The facilitated cellular uptake of micelles was realized by triggering azobenzene collapse that provoked PEG shedding, while Ce6 could be released rapidly by micelle disassembly from imidazole oxidation (Figure [5](#F5){ref-type="fig"}A). The ^1^O~2~-mediated cargo release not only overcame the limited diffusion range and short half-life of ^1^O~2~ but also decreased the oxygen level, which could, in turn, enhance internalization and increase the intracellular Ce6 concentration. *In vivo* imaging study demonstrated that more Ce6 were accumulated in the tumor from dually responsive (DR) micelles in contrast to free Ce6 (Figure [5](#F5){ref-type="fig"}B). *In vivo* efficacy study indicated that the multifunctional micelles could maximize the PDT antitumor efficacy via interactively triggered delivery of the PS (Figure [5](#F5){ref-type="fig"}C).

### Photothermal-responsive nanoplatforms

A photothermal responsive system induced by NIR light has gained acceptance for drug delivery in consideration of high efficiency, the noninvasive modality to tumor treatment, as well as the high spatial resolution of NIR light [@B119], [@B120]. Photothermal-response nanoplatforms also contribute to diffusion therapy of PS. Importantly, this system exhibits synergistic cancer therapy associated with hyperthermia and heat-induced local drug release. Recent photothermal nanoplatforms mainly include noble metallic nanoparticles (gold nanocages [@B121], gold nanorods [@B122]), semiconductor nanocrystals (CuS [@B123], WS~2~ [@B124], and MoS~2~ [@B125]) as well as carbon-based nanoparticles (carbon nanotubes [@B126], graphene [@B127], and carbon nanospheres [@B128]), organic dye molecules (ICG [@B129], IR780 [@B130]), and organic semiconducting polymer nanoparticles (polypyrrole [@B131], PEDOT:PSS [@B132]). Fu *et al.* developed a novel tumor-targeting photothermal heat-responsive nanoplatform by using dopamine-reduced graphene oxide nanosheets (rGO-PDA), mesoporous silica-coated on the rGO-PDA surface to load Ce6, and hyaluronic acid as a gate-keeper as well as a targeting moiety [@B133]. The nanoplatforms showed excellent photothermal conversion ability under near-infrared radiation and controllable Ce6 release with an NIR irradiation response. It could specifically deliver Ce6 to CD-44 over-expressing cancer cells for PDT. The combination of excellent NIR photothermal conversion ability and controllable Ce6 release conferred on the nanoplatforms enhanced photodynamic therapeutic efficiency.

Chemical effects of nanoplatforms for enhanced PDT
==================================================

The majority of the chemical factors that enhance the photodynamic effect are focused on overcoming the problem of hypoxia in tumor sites. Generally, nanoplatforms could load oxygen, or react with specific substances to produce oxygen in the tumor microenvironment, or produce oxygen under light stimulation.

Self-supplying oxygen nanoplatforms
-----------------------------------

In recent years, many studies have reported that various nanoplatforms, such as perfluorocarbons [@B134], hemoglobin [@B135], catalase [@B136], and manganese dioxide derivatives [@B137], [@B138], delivered oxygen to tumor sites to overcome anoxic environments. These substances show an improved PDT effect, and their mechanism of operation is slightly different, as explained in detail below.

### Oxygen affinity nanoplatforms

**Perfluorocarbons** are synthetic organic molecules, typically alkanes and their derivatives, whose hydrogen atoms are replaced by fluorine atoms [@B139], [@B140]. They show biologic inertness and low toxicity even at high doses and, therefore, can be used for drug delivery. Because of the exceedingly favorable nuclear magnetic resonance properties and the virtual absence of fluorine in the human body, the perfluorocarbon carriers can also be utilized for ^19^F magnetic resonance imaging (MRI) [@B141]. Furthermore, the unique electronic nature of C-F bonds endows the perfluorocarbon with excellent oxygen affinity, causing their oxygen-dissolving capacity to be much higher than that of other hydrocarbons or water and, therefore, have been widely explored for lung injury, emergency transfusion, and traumatic brain injury [@B142], [@B143]. The ^1^O~2~ lifetime in perfluorocarbon (on the milli-second scale) is much longer than that in the cellular environment or in water (on the microsecond scale). Because perfluorocarbons have high oxygen solubility and ^1^O~2~ retention ability, they can maintain higher oxygen content than non-perfluorocarbon systems for potential oxygen self-enriched PDT [@B144]-[@B147]. As displayed in Figure [6](#F6){ref-type="fig"}A, Liu\'s group designed fluorinated covalent organic polymers by cross-linking the photosensitizer meso-5, 10, 15, 20-tetra (4-hydroxylphenyl) porphyrin with perfluorosebacic acid and PEG by a one-pot esterification [@B148]. The fluorinated nanoplatforms showed efficient loading of perfluoro-15-crown-5-ether (PFCE) due to the fluorinated chains of perfluorosebacic acid. After chelating with ^99m^Tc^4+^ radio-isotope utilizing the porphyrin structure of THPP, the fluorinated nanoplatforms could be tracked by *in vivo* SPECT imaging (Figure [6](#F6){ref-type="fig"}B). Finally, greatly enhanced photodynamic treatment effect was observed in mice after injecting PFCE\@THPP~pf~-PEG because of the oxygen delivery by PFCE (Figure [6](#F6){ref-type="fig"}C). To increase the cell affinity and response of the fluorinated nanoplatforms, Ma *et al.* developed an oxygen self-sufficient fluorinated nanoplatform of pH-sensitive fluorocarbon-functionalized nanoparticles loaded with IR780, and used iRGD as a tumor-targeting and penetrating peptide [@B149]. This oxygen self-sufficient nanoplatform could significantly enhance the tumor oxygenation and increased the generation of ^1^O~2~ *in vitro* and *in vivo*. These nanoplatforms, when injected into orthotopic breast cancer model, could remarkably inhibit the primary tumor growth and reduce lung and liver metastases. The aforementioned methods may suffer from premature oxygen release and storage issues. Furthermore, it has been reported that the stability of fluorinated nanoplatforms is essential. To enhance the stability of the nanoplatforms, Song *et al* developed lipid-polymer bilaminar oxygen nanobubbles with Ce6 conjugated to the polymer shell using a combination of emulsion-solvent evaporation and internal phase separation [@B150]. The bilaminar shell of the nanobubbles rendered the nanobubbles biocompatible and stable. *In vitro* and *in vivo* results showed that nanobubbles exhibited much higher cellular uptake rates and tumor-targeting efficiency than free Ce6. A significant enhancement of photodynamic therapeutic efficacy was noticed due to the greatly enhanced ^1^O~2~ production powered by oxygen-encapsulated nanobubbles.

**Red blood cells** (RBC) are the primary oxygen source of our body tissues, carrying 270 million hemoglobin molecules. Due to the binding ability of each hemoglobin for up to four O~2~ molecules, RBCs have long been investigated for drug delivery. Moreover, natural RBC membranes could camouflage microparticles for successfully overcoming biological barriers with a long blood-circulation time. Taking advantage of these properties, Wang *et al.* developed RBC hybrid nanoplatforms, consisting of upconversion nanoparticles (UCNPs), and the rose bengal PS installation on the RBC surface [@B151]. Under hypoxic conditions, the inactive hypoxia probe could trigger the O~2~ release from oxygenated hemoglobin under NIR excitation, further improving the PDT efficiency. Also, RBC nanoplatforms delayed uptake by the mononuclear phagocyte system by preferentially binding to the endothelium and decreasing retention in the reticuloendothelial system. Thus, RBC nanoplatforms show enhanced PDT under near-infrared irradiation to realize effective solid tumor eradication. Wan *et al.* prepared nanoscale RBC carriers containing sufficient oxyhemoglobin and gas-generating agent ammonium bicarbonate (ABC) for co-loading and controlled release of ICG and DOX [@B152]. These nanoplatforms showed nearly identical PTT efficiency both *in vitro* and *in vivo*, but their PDT efficiency was improved significantly due to oxyhemoglobin. ABC was decomposed into NH~3~ and CO~2~, further triggering the rapid release of DOX exerting cytotoxic effects. The combination of enhanced PDT and released DOX significantly inhibited breast cancer cell growth in mice and induced cell apoptosis. *In vivo* experiments confirmed that the nanoplatforms almost completely ablated breast tumors and further suppressed tumor recurrence and metastasis.

**Hemoglobin** (Hb), the endogenous protein abundant in RBCs, has been used as an oxygen carrier for PDT. Compared to other carriers, hemoglobin is easily available and safe *in vivo*. However, the short circulation life, instability, and easy formation of dimers impair the treatment effect. To solve these problems, Wang *et al.* developed a hemoglobin polymer-conjugated nanoplatform as the carrier of both oxygen and the PS to enhance PDT [@B153]. The amphiphilic triblock copolymer, poly (ethylene glycol) methyl ether-block-poly acrylic acid-block-polystyrene, was synthesized by atom transfer radical polymerization. The polymer and PS were covalently conjugated with Hb, and, compared with free Hb, the resulting nanoplatform showed a high tolerance to oxidation and trypsin digestion while retaining its O~2~ binding capacity. More importantly, the nanoplatform could readily generate ^1^O~2~ and kill 4T1 cells *in vitro* under light irradiation, exerting better phototoxicity with the oxygen supply of Hb. In another study, Jiang*et al.* prepared Hb-linked conjugated polymer nanoparticles, which were encapsulated in fusogenic liposomes (Hb-NPs\@liposome) (Figure [7](#F7){ref-type="fig"}A) [@B154]. Due to the catalyzed activation of luminol, the conjugated poly\[2-methoxy-5-(2-ethylhexyloxy)-1,4-phenylenevinylene\] (MEH-PPV) polymer, by the oxygen supplied by Hb, the nanoparticles could acquire chemiluminescence resonance energy transfer to produce ROS. This novel system did not require an external light source and circumvented the insufficient level of molecular oxygen for PDT. The luminescing and O~2~-supplying system offers the possibility of simultaneous PDT and chemotherapy (Figure [7](#F7){ref-type="fig"}B).

### *In situ* generation of oxygen-nanoplatforms

**Catalase** is a specific catalytic enzyme with an extremely high turnover to decompose H~2~O~2~ into O~2~ and has been explored in combination with other therapeutic approaches to construct several types of nanoplatforms to relieve tumor hypoxia [@B155]-[@B158]. However, after systemic administration, catalase is unstable in the presence of proteases in blood circulation. Various methods, such as encapsulation of the enzyme into inorganic nanoparticles or polymeric capsules, have been designed to protect catalase from protease digestion [@B159], [@B160]. Liu\'s group designed a catalase enzyme-encapsulated, Ce6-loaded hollow silica nanoplatform with rationally pH-responsive charge-convertible, mitochondria-targeting surface engineering [@B161]. Within the acidic tumor microenvironment, the nanoplatform showed charge-conversion from negative to positive, accelerating cellular internalization and tumor retention. Also, the triphenylphosphine of this nanoplatform could enhance PDT by targeting mitochondria. Eventually, the nanoparticles could decompose endogenous H~2~O~2~ in the tumor and alleviate tumor hypoxia, greatly enhancing PDT treatment of solid tumors. Furthermore, the nanoparticles showed synergistic effects when combined with anti-PD-L1 checkpoint blockade to induce robust antitumor immunity, which could suppress tumor growth without direct light exposure. Subsequently, his group also loaded catalase into the capsule by in situ free-radical polymerization, using double-bonded meso-tetra(phydroxyphenyl)porphine as the cross-linker to enable condensed grafting of short polyethylene glycol chains on the protein surface as a permeable brush-like safeguard [@B162]. The catalase-entrapped nanocapsules exhibited efficient passive retention in tumors after intravenous injection, which could significantly overcome tumor hypoxia by triggering the decomposition of endogenous tumor H~2~O~2~ into oxygen, achieving a remarkable antitumor therapeutic effect. Also, the nanocapusles showed greatly prolonged blood circulation, with the blood half-life of ≈6.42 h and effective tumor accumulation of 6.03 ± 1.78% ID g^-1^. However, it was reported that the relative enzymatic activity of catalase-encapsulated nanocarriers might decrease during the synthetic processes. To tackle the issue, Zhao\'s group developed therapeutic nanoplatforms consisting of catalase-encapsulated β-cyclodextrin-HA nanoparticles loaded with adamantane-modified Ce6 by supramolecular means (Figure [8](#F8){ref-type="fig"}A) [@B163]. The obtained therapeutic nanoplatform could target overly expressed CD44 receptors on MDA-MB-231 cells, where the encapsulated catalase could decompose the endogenous H~2~O~2~ to generate O~2~ for alleviating hypoxia in cells incubated under hypoxic conditions. The nanoplatform also exhibited high cellular cytotoxicity under hypoxic condition because of the ability of catalase in mitigating hypoxia. *In vivo* experiments revealed that the tumor growth from group V was the most inhibited one among all groups, illustrating the highest antitumor efficacy of HA-CAT\@aCe6 (Figure [8](#F8){ref-type="fig"}B and [8](#F8){ref-type="fig"}C).

**Manganese dioxide (MnO~2~)-**based nanoplatforms have attracted considerable interest in bio-applications. In response to the low pH tumor microenvironment, MnO~2~ nanoparticles can be rapidly broken up. Therefore, MnO~2~-based drug nanoplatforms show enhanced drug release in the acidic tumor microenvironment [@B164], [@B165]. MnO~2~-based nanoplatforms could also catalyze H~2~O~2~ to produce O~2~ efficiently to improve tumor oxygenation *in vivo* [@B166]-[@B171]. Zhu *et al.* developed multifunctional Ce6-loaded MnO~2~ nanoparticles with surface polyethylene glycol modification (Ce6\@MnO~2~‐PEG) that could effectively strengthen the efficacy of PDT due to the increased intracellular O~2~ level generated from the reaction between MnO~2~ and H~2~O~2~[@B172]. *In vivo* results showed that Ce6\@MnO~2~-PEG nanoparticles could accumulate in the tumor, and were gradually decomposed into Mn^2+^ ions to offer a strong T~1~ MR contrast. The tumor oxygenation level greatly increased due to MnO~2~-triggered O~2~ production from H~2~O~2~ within the tumor microenvironment. Compared with traditional PS approved by the Food and Drug Administration, aza-boron-dipyrromethene (aza-BODIPY) derivatives have exhibited excellent photophysical properties, such as near-infrared absorption, strong visible light molar absorption coefficient, and good light stability [@B173], [@B174]. As shown in Figure [9](#F9){ref-type="fig"}A, Tang *et al* loaded aza-BODIPY photosensitizer and anticancer drug DOX onto the hydrangea-structured MnO~2~ nanoparticles, further modifying with amphiphilic polyvinylpyrrolidone to increase the physiological stability and biocompatibility [@B175]. The resultant nanoplatform (MDSP) showed strong NIR absorption, significant photothermal effect, rapid degradation, and efficient oxygen-self-generation in the presence of H~2~O~2~. Especially, MnO~2~ could react with H~2~O~2~ and H^+^ in the tumor microenvironment to produce oxygen and overcome tumor hypoxia, enhancing the chemotherapeutic efficiency and PDT. As demonstrated by *in vivo* fluorescence and photoacoustic imaging, MDSP nanoparticles were preferentially accumulated at the tumor site, which could induce hyperthermia to alleviate hypoxia, promote the uptake of therapeutic nanoparticles, and further reduce the resistance to improve the therapeutic efficiency (Figure [9](#F9){ref-type="fig"}B). Besides, organic semiconductor PS is also widely studied. Zhu *et al.* developed near-infrared light excitable semiconducting hybrid nanoparticles of poly(cyclopentadithiophene-alt-benzothiadiazole) [@B176] in which the core served as the photodynamic agent for NIR fluorescence imaging, while the MnO~2~ nanosheets converted H~2~O~2~ to O~2~ in hypoxic and acidic tumor microenvironment. In contrast to the uncoated nanoparticles, the oxygenic nanoparticles generated 2.68-fold more ^1^O~2~ in the hypoxic and acidic conditions under NIR laser irradiation at 808 nm. Due to such an oxygen-generation property, the nanoplatforms could effectively eradicate cancer cells both *in vitro* and *in vivo*.

Despite the use of MnO~2~ nanoparticles to generate O~2~ or consume GSH in the tumor microenvironment, several limitations, including rapid consumption of MnO~2~, transient O~2~ generation or GSH depletion, hamper the efficient regulation of tumor hypoxia and fail to continuously and synchronously enhance ROS-based therapeutic effect [@B177]. Overcoming these drawbacks requires the development of a persistent strategy to regulate tumor microenvironment. To enhance PDT efficiency, Kim *et al.* developed biocompatible manganese ferrite nanoparticles anchored onto mesoporous silica nanoparticles [@B178]. Exploiting the continuous generation of oxygen by MnFe~2~O~4~ nanoparticles through the Fenton reaction under physiological conditions, the nanoplatform could enhance ROS generation of PS, thus improving the therapeutic outcome of PDT for tumors *in vivo*. Furthermore, these nanoplatforms exhibited T~2~ contrast effect in MRI, allowing *in vivo* tracking of nanoplatforms. Based on previous findings, Zhang *et al.* developed biocompatible nanoplatforms by concentrating a coating of porphyrin-based MOF as the PS and MnFe~2~O~4~ as the nanoenzyme (Figure [10](#F10){ref-type="fig"}A) [@B179]. The MnFe~2~O~4~\@MOF nanoplatform exhibited both catalase and glutathione peroxidase-like activities. Once internalized in the tumor, the nanoparticles could continuously catalyze H~2~O~2~ to produce O~2~ by cyclic Fenton reaction and also persistently reduce GSH in the presence of H~2~O~2~, decreasing the depletion of ROS upon laser irradiation during PDT. MnFe~2~O~4~\@MOF was also used for MRI-guided precision cancer therapy (Figure [10](#F10){ref-type="fig"}B). An enhanced photodynamic therapeutic effect arose from simultaneously self-producing O~2~ and self-decreasing GSH (Figure [10](#F10){ref-type="fig"}C).

Besides MnO~2~ carriers for PDT, hybrid nanoplatforms assembled from MnO~2~ and other nanomaterials are sometimes more effective in enhancing PDT. Bhattacharyya *et al.* developed unique two-dimensional hybrid nanoplatforms based on PEGylation of MnO~2~-decorated p-MoS~2~/n-rGO heterojunction nanosheets [@B180]. The resulting nanoplatforms showed better biocompatibility and colloidal stability in physiological solutions. The p-n heterojunction directed NIR-triggered generation and separation of electron-hole pairs, which improved the production of ROS via photocatalysis. Also, MnO~2~ increased intracellular O~2~ by reacting with endogenous H~2~O~2~ in the cellular microenvironment. The hybrid nanoplatforms have been demonstrated as PDT-enhanced agents for cancer therapy. In another study, Wang *et al.* developed a chemo-photodynamic nanoplatform (FMZ/DC) by one-pot encapsulation of g-C~3~N~4~ and DOX in ZIF-8, then loading MnO~2~ nanodots and surface-modifying F127 (Figure [11](#F11){ref-type="fig"}A) [@B181]. The hybrid nanoplatforms could generate oxygen upon the addition of H~2~O~2~, further demonstrating the enhanced therapeutic effects for both chemotherapy and PDT therapy. *In vivo* tumors treated with FMZ/DC began to shrink after 2 days of chemo-photodynamic therapy. The outstanding therapeutic effect could be ascribed to the oxygen-generating ability of the nanoplatform, improving the efficiency of photodynamic and chemotherapeutic treatments (Figure [11](#F11){ref-type="fig"}B and [11](#F11){ref-type="fig"}C).

Encouraged by the excellent catalytic performance of natural enzymes, varieties of synthetic structures have been designed to mimic the functions and complexities of natural enzymes over the past few decades. Various artificial nanozymes are emerging and attracting extensive research interest [@B182], [@B183]. Platinum nanoparticles are well-known catalysts for many chemical reactions, whose enzyme mimetic activities have been reported previously [@B184]. As illustrated in Figure [12](#F12){ref-type="fig"}A, Zhang *et al.* developed a porphyrinic Zr-MOF derived from PS and Zr in which Pt nanoparticles were homogeneously decorated on MOF via an *in-situ* reduction and further coated with PEG to greatly improve the biocompatibility and physiological stability [@B185]. The obtained nanoplatform with high catalase-like activity induced the decomposition of H~2~O~2~ to produce O~2~ at the hypoxic tumor site, facilitating the formation of cytotoxic ^1^O~2~ to kill cells. The tumor growth was completely inhibited when the mice were injected with the nanoplatform (PCN-224) after irradiation treatment (Figure [12](#F12){ref-type="fig"}B and [12](#F12){ref-type="fig"}C). Thus, the nanoplatform exhibited much improved PDT efficiency via H~2~O~2~-activated generation of O~2~ and light-irradiated formation of ^1^O~2~. Similarly, Wei *et al.* designed Pd\@Pt bimetallic nanoplates, which were further covalently conjugated with Ce6 and bifunctional PEG [@B186]. The nanoplatform could produce O~2~ over a long period by reacting with H~2~O~2~ in the tumor sites. Also, the moderate photothermal effect of the nanoplatform under 808 nm laser irradiation could further improve the PDT efficacy in hypoxic tumors by accelerating its catalytic decomposition of H~2~O~2~. Both *in vitro* and *in vivo* results indicated that the nanoplatform effectively delivered PS to cancer cells/tumor sites and triggered the decomposition of endogenous H~2~O~2~ to generate oxygen, resulting in a remarkably enhanced PDT efficacy.

### Other nanoplatforms for generating oxygen

Besides the nanoplatforms mentioned earlier, oxygen bonding and in situ generation of oxygen, some researchers have attempted to endow nanoplatforms with oxygen by other means to enhance PDT. Wang *et al.* developed core-shell nanoparticles based on a double emulsion method, wherein the H~2~O~2~/ poly(vinylpyrrolidone) complex and poly(lactic-co-glycolic acid) (PLGA) served as the core and shell, respectively. The hydrophilic H~2~O~2~/poly(vinylpyrrolidone) complex acted as an oxygen source, while hydrophobic IR780 was the PTT/PDT agent. When the resultant nanoplatforms were internalized by HepG2 cells, they could generate the photothermal effect where ROS was released to kill cancer cells under an 808 nm laser irradiation. Moreover, the encapsulated H~2~O~2~ could supply additional oxygen and, in turn, significantly enhance the PDT effect [@B187]. The nanoplatforms accumulated in the xenograft tumor and could inhibit tumor growth due to combinational PTT and enhanced PDT upon NIR light irradiation. Xie *et al.* developed an O~2~-loaded pH-responsive multifunctional nanoplatform (UC\@mSiO~2~-RB\@ZIF-O~2~-DOX-PEGFA) with enhanced chemo-photodynamic therapeutic effect [@B188]. NaYF~4~:Yb/Er\@NaYbF~4~:Nd\@NaGdF~4~ nanoparticles were employed as both upconversion/MRI matrix and motivator for rose red PS in PDT with deep penetration depth. Zeolitic imidazolate framework-90 was capped outside of mSiO~2~ as an O~2~ reservoir to quickly release O~2~ in the tumor microenvironment, thereby improving the PDT efficiency. Additionally, DOX and NH~2~-poly(ethylene glycol)-modified folic acid were covalently adsorbed on the surface of nanoparticles for synergetic therapy. Li *et al.* developed upconversion nanophotosensitizers with hyperbaric oxygen (HBO) to change the extracellular matrix for enhanced photodynamic cancer therapy [@B189]. The UCNPs were developed for Nd^3+^-sensitized sandwiched structure, wherein the upconversion core served as a light transducer to transfer energy to the neighboring rose bengal to produce ROS. With HBO, the photodynamic process could induce abundant ROS in the intrinsically hypoxic tumor. Furthermore, HBO-assisted PDT decomposed collagen in the extracellular matrix of tumors and facilitated the diffusion of oxygen and penetration of nanoplatforms into the deeper area of the tumor. Such a synergic effect eventually caused enhanced therapeutic efficacy at a low laser power density as compared with those using UCNPs alone.

Water-splitting materials
-------------------------

Due to possibly worsening hypoxia, the PDT may cause irreversible tumor metastasis or drug resistance. Highly efficient production of O~2~ can potentially compensate for the tumor hypoxic microenvironment. Compared to the aforementioned nanoplatforms able to produce oxygen, water is the most abundant compound in the physiological environment [@B190] and could provide unlimited raw material for O~2~ generation. To date, a variety of splitting materials have been innovatively constructed to generate oxygen and hydrogen for clean, renewable resources, also extending the strategy to PDT [@B191]. The commonly used water-splitting nanoplatforms include oxides (titanium dioxide), carbon or nitrogen compounds (carbon nitride and MXene), and sulfides.

**Titanium dioxide (TiO~2~)** has received considerable attention for its adjustable band gap, band position, superior photostability, high intrinsic catalytic activity, abundance, low toxicity, and inexpensiveness [@B192]-[@B194]. Yang *et al* developed carbon-nanodot-decorated TiO~2~ nanotubes as a nanoplatform for PDT [@B195]. In this formulation, carbon dots (CDots) could increase the light absorption response and narrow the band-gap compared with anatase TiO~2~ nanoparticles. Interestingly, CDots/TiO~2~ nanotubes could absorb the 650 nm NIR light, where the emission wavelengths (325-425 nm) of CDots excite TiO~2~ nanotubes to form electron/hole (e^-^/h^+^) pairs, inducing the reaction with the adsorbed oxidants to produce ROS. Besides, the CDots showed high chemical catalytic activity for H~2~O~2~ decomposition. The excellent PDT performance actuated by 650 nm light was verified by *in vivo* assays. Using an organometallic ruthenium complex (N~3~) as a conjugator, Gilson *et al* prepared TiO~2~-N~3~ nanoplatforms [@B196]. Upon exposure of TiO~2~-N~3~ to light, N~3~ injected electrons into TiO~2~ to produce three- and four-fold hydroxyl radicals and hydrogen peroxide. Furthermore, the inability of TiO~2~ to produce H~2~O~2~ under hypoxic conditions suggested that N~3~ facilitated the depletion of residual H~2~O~2~ and rapid conversion of the low oxygen concentration into •OH, thus increasing the concentration of this species. TiO~2~-N~3~ maintained three-fold higher hydroxyl radicals than TiO~2~ under hypoxic conditions via N~3~-facilitated electron-hole reduction of adsorbed water molecules. These results demonstrated a mechanism to convert and maintain cytotoxic •OH production by harnessing the reductive power of ruthenium complexes, which efficiently reduced low levels of oxygen for ROS production.

**Carbon nitride** (C~3~N~4~) has received considerable attention for the adjustable band gap and band position [@B197], [@B198]. After the modification, water splitting can be driven under high penetrable red light \>600 nm, which makes C~3~N~4~ suitable for *in vivo* therapy. Most importantly, due to the absence of metal elements, C~3~N~4~ is thought to be a highly biocompatible material for biomedical applications. As presented in Figure [13](#F13){ref-type="fig"}A, Zheng *et al.* developed CDots-doped C~3~N~4~ nanoparticles, and further modified with an amphipathic polymer (PpIX-PEG-RGD) [@B199]. The as-prepared nanoplatform could split water to generate O~2~ under 630 nm laser radiation with high efficiency. The PS could further transmit the energy to the produced O~2~ to generate cytotoxic ^1^O~2~. *In vitro* study showed the nanoplatform could increase the intracellular O~2~ concentration and improve the ROS generation in both hypoxic and normoxic environments. After the injection, PpIX fluorescence started to accumulate in the tumor (Figure [13](#F13){ref-type="fig"}B). The *in vivo* experiment indicated that CDots-doped C~3~N~4~ (CCN) nanoparticles and PpIX showed little inhibitory effects on 4T1 tumors. However, treatment with polymer-modified, CDots-doped carbon nitride nanoparticles (PCCN) exhibited remarkable growth inhibition against tumors with only one injection (Figure [13](#F13){ref-type="fig"}C and [13](#F13){ref-type="fig"}D), which could be attributed to its tumor targeting and O~2~ generation. Recent studies also reported that metal ion-doped C~3~N~4~ nanoplatforms showed better-enhanced PDT. Jiang *et al.* developed the fusiform Fe^III^-doped C~3~N~4~ nanoplatform, further modified by mitochondria-targeting molecular (4-carboxybutyl) triphenylphosphonium bromide (TPP) [@B200]. The ultrahigh surface area of the nanoplatform enhanced the loading capacity of methylene blue, while mitochondria-targeting TPP agent improved the ROS concentration, thus accelerating the mitochondrion dysfunction and further triggering cell death during PDT. The doping of Fe^III^ showed excellent catalytic performance towards H~2~O~2~ in cancer cells to generate O~2~, thus overcoming tumor hypoxia and enhancing the PDT efficacy. In addition, the introduction of Fe^III^ endowed the Fe^III^-doped C~3~N~4~ nanoplatform with an effective T~1~-weighted MRI contrast ability for simultaneous imaging and therapy. Likewise, Qu *et al.* reported that the combination of Cu^2+^ and g-C~3~N~4~ nanosheets (Cu^2+^-g-C~3~N~4~) led to increased light-triggered ROS generation as well as the depletion of intracellular GSH levels [@B201]. Consequently, the ROS generated under light irradiation could be depleted less by reduced GSH, thus improving efficiency. Importantly, Cu^2+^-g-C~3~N~4~ nanosheets could catalyze the reduction of molecular oxygen to the superoxide anion or hydrogen peroxide to the hydroxyl radical, both of which accelerated the generation of ROS. This synergy of improved ROS generation and GSH depletion could enhance the efficiency of PDT for cancer therapy.

Wang *et al.* developed a biomimetic ultrathin graphdiyne oxide from oxidized and exfoliated graphdiyne, which was further modified by iRGD peptide-modified RBC membrane [@B202]. The obtained nanoplatform showed prolonged blood circulation via RBC membrane camouflage along with enhanced extravascular and hypoxic region penetration by a functional iRGD peptide. The nanoparticles could efficiently catalyze water oxidation to release O~2~ and generate ^1^O~2~ using 660 nm irradiation. More importantly, the hyperthermia effect of ultrathin graphdiyne oxide could conveniently cause dilation of vessels and blood perfusion for overcoming perfusion-limited hypoxia. Consequently, with O~2~ evolving from photocatalysis water splitting together with blood perfusion from photothermal conversion, this nanoplatform alleviated diffusion- and perfusion-limited hypoxia synchronously and further enhanced PDT.

The above-mentioned results indicated that numerous materials could improve intratumoral O~2~ and ROS supplementation for enhanced PDT (Table [2](#T2){ref-type="table"}). However, the limited O~2~ binding sites in Hb and low solubility of O~2~ in perfluorocarbon restricted the efficacy. Additionally, the low intracellular concentration of H~2~O~2~ significantly limited the O~2~ production yield and thus achieved only moderate efficacy in cancer therapy. As the most abundant compound in living organisms, water provides enough O~2~ for *in vivo* PDT. Therefore, the construction of highly catalytic nanoplatforms is essential for PDT.

Physical effects of nanoplatforms for enhanced PDT
==================================================

The efficiency of PDT is also affected by physical factors, such as light sources [@B203], magnetic field [@B204], electric fields [@B205], microwaves [@B206], and ultrasound [@B207]. Compared with light, the microwave is a superior energy source to trigger the ROS generation for tumor therapy. However, microwave energy is considered to be insufficient for inducing free radical generation, making microwave dynamic therapy subject to certain restrictions [@B208]. Ultrasound can activate PS for tumor cell destruction useful for penetrating deep tissues. This novel approach is known as sonodynamic therapy [@B209]. Some studies have shown that the efficiency of ultrasound-activated PS needs to be further improved. The microwave of the electromagnetic spectrum has been extensively explored for tumor ablation in clinical settings, especially microwave thermal therapy because of the penetration depth in tissues, high heating efficiency, and negligible side effects. Magnetic nanoparticles are promising candidates for controlled drug delivery, hyperthermia therapy, and MRI [@B210]. When subjected to oscillating magnetic fields, the magnetic nanoplatforms could generate heat for targeted tumor therapy. Moreover, magnetic nanoplatforms can absorb NIR light to induce hyperthermia. Therefore, a combination of magnetic nanoparticles and the PS in nanoplatforms leads to enhanced PDT efficacy. Some physical effects to enhance PDT are summarized in the Table [3](#T3){ref-type="table"}.

X-rays nanoplatforms
--------------------

Most of the solid tumors are located several millimeters under human skin, whereas, the penetration depth of UV/visible light into biological tissues is merely several micrometers [@B211]. Such limited penetration depth results in low tumor-killing efficiency. Many efforts have been devoted toward the development of the novel nanoplatforms to surmount the challenges from such poor and limited light tissue penetration. These nanoplatforms, one the one hand, involve the introduction of enhanced chemi- or bioluminescent probes as well as multi-photon and upconverting materials. On the other hand, they utilize external ionizing radiation to penetrate deep into the human body as a neoadjuvant treatment. As is widely accepted, X-rays exhibit a high penetration depth in the human body for clinical imaging. It holds the potential to become an ideal excitation source for activating PS accumulated in deep tumor tissue [@B212], [@B213]. In a typical X-rays assisted PDT, the absorbed X-ray energy was converted into photons with the appropriate wavelength, which were further absorbed effectively by PS. The resultant ROS from PS could directly damage the tumor cells, and the absorbed ionizing radiation could also generate radical species and break DNA double-strands [@B214], [@B215]. To match the energy difference between X-rays (keV-MeV) and the light absorbed by PS (eV), lanthanide-based scintillators and heavy metals have been adopted to absorb X-rays and transmit the energy to PS, leading to efficient luminescence in the visible light region. Since Tb^3+^ shows efficient green luminescence that matches well with the absorption band of porphyrin. Chen\'s group synthesized water-soluble LaF~3~:Tb^3+^-porphin conjugates to study ^1^O~2~ generation under X-rays irradiation. Anthracenedipropionic acid (ADPA) was used to measure the ^1^O~2~ generated by the porphin and LaF~3~:Tb^3+^-porphin conjugates. Upon X-rays irradiation, the luminescence of ADPA quenched much faster in LaF~3~:Tb^3+^-porphin conjugates than in the porphin solution. Therefore, high production of ^1^O~2~ in the LaF~3~:Tb^3+^-porphin conjugates was verified because of the energy transfer from the LaF~3~:Tb^3+^ nanoparticles to porphin [@B216]. Similarly*,* mesoporous LaF~3~:Tb^3+^ nanoparticles were proposed to load rose bengal for establishing an efficient fluorescence resonance energy transfer system [@B217]. These results indicated that a large amount of ^1^O~2~ could be generated in X-rays PDT for deep-seated tumor treatment. Moreover, recent years have witnessed the development of*in vivo* applications of X-rays PDT. Wang *et al* developed hybrid nanoplatforms based on LiLuF~4~:Ce\@SiO~2~\@Ag~3~PO~4~\@Pt(IV) to enhance the curative effects of X-rays PDT (Figure [14](#F14){ref-type="fig"}). LiLuF~4~:Ce nanoparticles were employed as the scintillator, and a cisplatin prodrug Pt(IV) was used as a sacrificial electron acceptor to increase the yield of hydroxyl radicals by boosting the separation of electrons and holes in Ag~3~PO~4~. Cisplatin was produced when Pt(IV) accepted electrons, which could damage the deoxyribonucleic acid in cancer cells, thereby enhancing the effect of X-rays PDT [@B218]. To endow X-rays PDT with diagnosis information, enriched scintillation nanoparticles (CeF~3~:Gd^3+^,Tb^3+^), coated with mesoporous silica for loading rose bengal, were developed in the treatment of deep-seated tumors [@B219]. The results showed an efficient tumor regression with synergistic nonradioactive radio-/photodynamic therapy under the guidance of computed tomography (CT) and MRI*in vivo*. Besides, other nanoplatforms of mesoporous silica-coated gold nanorods with conjugated europium (Eu) complexes were proposed for photothermal and X-rays PDT. Europium (Eu) complexes efficiently transfer the X-rays energy to hematoporphyrin for PDT treatment. *In vitro* and *in vivo* studies indicated that nanoplatforms showed CT and photoacoustic imaging for deep tumor penetration. An effective suppression of tumor progression was verified under X-rays and laser irradiation *in vivo* [@B220]. Besides, QDs-based, silicon-based, and metal-based nanoscintillator have also been proposed and studied [@B221]. In view of size-dependent photoluminescence of QDs and silicon semiconductor nanoparticles, their absorbance and photoluminescence could easily be adjusted for PDT. Moreover, they showed well biodistribution properties and could be eliminated from the body in a relatively short time. Remarkably, QDs could transfer energy to a molecular PS or directly to molecular O~2~, both of which can generate ^1^O~2~ for X-rays PDT. As metal-based nanoscintillators, gold nanoparticles exhibited excellent absorbers of X-rays and have been studied as radiosensitizers for radiotherapy. Deng and co-authors developed novel mitochondria targeted PLGA-based nanoplatforms containing ultrasmall gold nanoparticles and verteporfin. The nanoplatforms demonstrated a higher ability to generate ^1^O~2~ compared to PLGA-loaded verteporfin. Furthermore, they produced a large amount of ^1^O~2~ within the mitochondria *in vitro* upon X-rays radiation, thus triggering mitochondria-related apoptosis of cancer cells. Obviously inhibited growth of *in vivo* tumor with only a fraction of radiotherapy dose by X-rays PDT [@B222]*.* Despite some progress have been made, some *in vivo* studies are conducted by intratumoral injection of nanoplatforms, which is ineffective to the non-invasive clinical treatment of deep-seated tumor due to poor specificity upon their uptake in these cancer cells. What\'s more, the interplay between PDT and ionizing irradiation remain unclear, and the low-dose irradiation, energy conversion as well as safety profiles need further explorations.

Surface plasmon resonance of nanoplatforms
------------------------------------------

The electromagnetic-near-field enhancement mechanism of plasmonic nanoparticles has been exploited to control ^1^O~2~ generation. When the localized surface plasmon resonance (SPR) band was close to the absorption band of nearby PS, the absorption coefficient of PS could be significantly improved by the localized electric field, thereby increasing the production efficiency of ROS [@B223], [@B224]. So far, plasmonic gold-based nanoplatforms have been explored to enhance the ^1^O~2~ by strong and tunable SPR. Li *et al.* developed a nanoplatform composed of mesoporous silica-coated gold nanorods incorporating indocyanine green [@B225]. The SPR of gold nanorods was regulated to overlap with ICG exciton absorption. Such an overlap greatly increased the ^1^O~2~ yield of incorporated ICG under laser excitation. Furthermore, the nanoplatform possessed a synergistic PTT effect based on both Au nanorod and ICG. The integrated strategy significantly improved photodynamic destruction of breast tumor cells and inhibited the growth of orthotopic breast tumors in mice through the synergistic effect of PDT and PTT. To exploit the SPR advantages of gold nanorods, the nanoplatform consisting of NaYF~4~:Yb/Er conjugated with gold nanorods was prepared to boost the therapeutic efficiency of PDT [@B226]. Methylene blue was embedded inside the silica shell to increase photostability and prevent drug leakage. UCNPs could convert NIR light to visible light to excite methylene blue for the generation of ROS. More importantly, gold nanorods could effectively increase upconversion efficiency and ROS content through a localized SPR effect. The mechanism of plasmon-enhanced PDT was verified by enhancing upconversion luminescence intensity through the plasmonic field and by increasing the light-harvesting capability and absorption cross-section of the system. Consequently, the nanoplatform could produce ROS and undergo efficient PDT *in vitro* and *in vivo*. The plasmonic Au nanoparticles integrated with the black phosphorus nanosheet simultaneously enhanced the ^1^O~2~ generation and hyperthermia by localized SPR effects for cancer phototherapy [@B227]. The hybrid nanoplatform not only significantly increased 3.9-fold ^1^O~2~ production of black phosphorus nanosheet, but also achieved 1.7-fold increase in photothermal conversion efficiency upon single laser irradiation with 670 nm. When mice were subjected to laser irradiation, the nanoplatform showed stronger inhibition of tumor growth than other controls. The nanoplatform could almost completely restrain the tumor growth over 14 days due to enhanced PDT/PTT synergistic therapeutic effects.

Other nanoplatforms through resonance energy transfer
-----------------------------------------------------

Although conventional single chromophore-based PS like porphyrin derivatives [@B228], methyl blue [@B229], rose bengal [@B230], merocyanine 540 [@B231], and heavy metal complexes possess therapeutic capabilities for cancer, their absorption intensities and ^1^O~2~ generation efficiencies in the NIR region are not ideal. To improve NIR-mediated PDT of the existing PS, UCNPs have been developed as *in vivo* phototransducers that could emit in the visible spectrum when excited by NIR light, overlapping with the activation wavelengths of the existing PS. Liu *et al.* constructed a multilayered upconversion nanoplatform consisting of three functional layers, where the upconversion nanoparticles served as the core and light-sensitive conjugated polymers and apo-transferrin-titanocene (Tf\@Tc) as shells [@B232]. Under NIR irradiation, apparent energy transfer occurred from the core to the polymer and Tc components in the shell, producing ROS and free radicals for cancer cell killing. *In vitro* cellular assays revealed the synergistic therapeutic effect of the conjugated polymer and Tc as PS. *In vivo* studies showed that tumor growth was significantly inhibited in mice receiving the theranostic platform and NIR irradiation. Also, the tin tungstate (SnWO~4~) generated great attention, because its unique band structure has remarkable visible light active photocatalytic performance, which is not found in any other tungsten-based binary or ternary compounds. Zhang *et al.* developed hybrid nanoplatforms based on the conjugation of needle-like SnWO~4~ nanocrystals and UCNPs [@B233]. The UCNP-emitted light of the nanoplatform was effectively absorbed by SnWO~4~, triggering the type-I PDT process to activate ROS maxima. The strong X-ray attenuation capacity of both tungsten and tin elements qualified the USWs as excellent radio-sensitizers for radiotherapy enhancement, which played a complementary role in PDT treatment. The quantum efficiency of UCNPs and consequent PDT outcomes are still suboptimal and relatively high-power intensity of the laser excitation sources are typically required. To extend NIR PS options with improved ^1^O~2~ efficiency, NIR-absorbing dyad PS based on resonance energy transfer have been developed, which have increased absorption intensity to maximize the use of absorbed photons, and greatly improve the efficiency in concomitant ^1^O~2~ generation. Huang *et al.* developed a dyad molecule based on the integration of the energy-donor moiety (distyryl-BODIPY) and PS (diiodo-distyryl-BODIPY) by click chemistry [@B234]. The dyad molecules encapsulated with biodegradable copolymer pluronic F127-folic acid could form uniform and water-soluble nanoparticles (Figure [15](#F15){ref-type="fig"}A), and displayed significantly enhanced absorption and ^1^O~2~ efficiency relative to that of the acceptor moiety of the PS alone in the NIR region. *In vitro* RET-BDP-TNM showed higher fluorescence intensity than RETBDP-NNM because of the folic acid ligand at the tumor site (Figure [15](#F15){ref-type="fig"}B). With an exceptionally low-power NIR LED light irradiation, tumor growth (group 6) was significantly suppressed, as shown in Figure [15](#F15){ref-type="fig"}Cand [15](#F15){ref-type="fig"}D. This result indicated RET-BDP-TNM could produce strong tumor PDT.

Conclusions and Perspective
===========================

Overall, noninvasive PDT represents an effective and highly selective tumor-ablative therapy in clinical applications. Good therapeutic effect and the possibility of the parallel application of PDT with other therapeutic protocols make it a frequently used strategy in many fields of medicine. In this review, we summarized the latest achievements and breakthroughs in constructing versatile nanoplatforms for enhanced PDT from a broad perspective. A variety of effective and proven approaches, such as stimulating a responsive release, tumor-targeting ability, O~2~ self-sufficient property, photocatalytic performance, physical effect (X-rays and surface plasmon resonance), and improvement through resonance energy transfer, were also discussed in detail.

Despite remarkable progress, there are still several considerable challenges facing the preparation of engineered nanoplatforms and their translation into clinical practice. Traditional nanoplatforms usually experience early recognition by the immune system and quick clearance from blood circulation, leading to low accumulation at the tumor site. Although some targeting nanoplatforms enhanced PDT, the local concentration was still relatively low compared to the total administered dose. Since the average distance of ^1^O~2~ diffusion is around 100 nm, targeting groups on nanoplatforms can increase their internalization in tumor cells for enhanced PDT. Thus, in the future, multiple organelle-targeting functions need to be explored for PDT, involving molecular recognition of overexpressed cellular receptors in the targeted area. Besides imparting tumor selectivity, another critical area to focus on is preventing unwanted side effects of nanoplatforms to the living organisms, thereby ensuring their compatibility and biosafety.

Currently, the performance of PS has limitations. Therefore, exploration of new PS, especially with high efficiency, is a primary focus in photodynamic research. The current complicated methods may have an impact on the application and performance of nanoplatforms. Therefore, another area of pursuit is of the relatively simple and smart methods for engineering nanoplatforms with sophisticated synthetic processes and formulations. However, another major challenge is the fundamental clinical requirements for the mass production of these nanoplatforms. Fox example, biodegraded hollow MOF-based nanoplatforms possess an efficacious PS loading capacity and maintain the high oxygen yield. Additionally, physicochemical characterization of nanoplatforms in terms of size, zeta potential, surface chemistry, colloidal stability, and, most importantly, safety protocols are needed.

The biggest payoff of versatile nanoplatforms contributes to the realization of theranostics, the integrated function of therapy and diagnostics by a single nanoformulation. For example, real-time monitoring of the therapeutic action is desired*in vitro* and even *in vivo*. It would be highly significant to provide real-time and on-site outcomes for patients for their post-treatment evaluation. Besides, it has been reported that PDT might result in cancer resistance at the cellular and molecular level. Combining PDT with different therapeutic modalities, such as chemotherapy or photothermal therapy, is crucial for further optimization of therapeutic efficiency. The mechanisms underlying the synergy between multi-modal theranostics need to be explored. In particular, the therapeutic effect of 1+1 = \>2 must be exerted rather than the additive effect of the individual features, the mechanism of synergy between multi-modal theranostics also needs to be deeply explored. The combination of different modalities is expected to provide functional compensation, diagnostic accuracy, and improved therapeutic efficiency.

Finally, most of the tumors are located deep inside the body rather than on the surface, requiring improved deep penetrating ability of PDT for deep-seated therapy. Immunotherapy has recently gained immense credence for eliminating distant metastatic cancer cells and remove residual cancer cells in the body. Thus, the synergistic use of deep tissue PDT and immunotherapy offers unique advantages in treating both deep-seated primary tumors and distant metastatic tumors. The successful translation of these nanoplatforms to clinical applications is anticipated in the near future upon satisfactory tackling of the current critical issues.
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![Schematic illustration of the versatile nanoplatforms for enhanced PDT.](thnov10p7287g001){#F1}

![**A.** Membrane-anchoring PS for enhanced PDT. Self-assembly of chimeric peptides into nanoparticles and the charge reverse at tumor environment (left), resulting in cell membrane disruption and cell necrosis (right). Adapted with permission from ref. [@B53]. Copyright 2017 Wiley-VCH. **B.** Intranuclear PS delivery and PS for enhanced PDT. (1) Schematic illustration of sequential-targeted PDT based on Ce6\@MSNs-RGD/TAT. (2) Tumor growth curves of different groups of tumor-bearing mice after PDT. (3) Photographs of the mice taken after 0 day, 7 and 15 days of PDT. Adapted with permission from ref. [@B56]. Copyright 2014 Wiley-VCH. **C.** Schematic representation of nanoplatforms and the directed attack of cancer cell lysosomes by NO and ROS under near infrared (NIR) light irradiation. Adapted with permission from ref. [@B66]. Copyright 2016 Royal Society of Chemistry.](thnov10p7287g002){#F2}

![**A.** Schematic illustrations of ALA pseudopolyrotaxane prodrug micelles. Adapted with permission from ref. [@B88]. Copyright 2016 Royal Society of Chemistry. **B.** Schematic illustrations of PCPNs\@Lip/DLC for enhanced PDT. Adapted with permission from ref. [@B93]. Copyright 2017 Royal Society of Chemistry.](thnov10p7287g003){#F3}

![**A.** Redox amphiphile for enhanced PDT. Adapted with permission from ref. [@B102]. Copyright 2019 American Chemical Society. (1) Schematic illustration of GSH-responsive intracellular activation of amphiphilic nanoplatforms and the tumor-targeted PDT*.* (2) *In vivo* fluorescence imaging of the 4T1 tumor-bearing mice after intravenous injection of 5,10,15,20-tetrakis (4-sulfophenyl) porphyrin (TPPS) and PEG-TPP-DNB micelles. **B.** H~2~O~2~-responsive biodegradable nanomedicine for imaging-guided PDT. Adapted with permission from ref. [@B106]. Copyright 2019 Elsevier. (1) Schematic illustration of the synthesized photosensitizer (MBPB) and BSA-MBPB nanoplatforms, *in vivo* fluorescence (2) and photoacoustic imaging (3) before and after 1, 3, 6, 12 and 24 h post injection of nanoplatforms.](thnov10p7287g004){#F4}

![Polymeric micelles for enhanced PDT via interactively triggered PS delivery.**A.** Illustration of the interactively hypoxia- and singlet oxygen-sensitive tailor polymeric micelles. **B.** *In vivo* fluorescent imaging of the tumor and healthy organs up to 24 h after intravenous injection of free Ce6, Ce6-loaded SR micelles, and Ce6-loaded DR micelles. **C.** Relative tumor volume upon treatment with DR micelles and control formulations (SR micelles, free Ce6, and PBS). Adapted with permission from ref. [@B118]. Copyright 2018 American Chemical Society.](thnov10p7287g005){#F5}

![Covalent organic polymers for enhanced PDT. **A.** Scheme illustrating the synthesis route of THPP~pf~-PEG and the subsequent PFCE loading. **B.** SPECT images of 4T1 tumor-bearing mice with the injection of PFCE\@THPP~pf~ (^99m^Tc)-PEG recorded at different time intervals. **C.** Tumor growth curves of four groups of mice after treatments as indicated. Adapted with permission from ref. [@B148]. Copyright 2018 Wiley-VCH.](thnov10p7287g006){#F6}

![**A.** Schematic illustration of the preparation of Hb-NPs\@liposome. **B.** the luminescing and oxygen-supplying system for phototherapy. Adapted with permission from ref. [@B154]. Copyright 2019 Wiley-VCH.](thnov10p7287g007){#F7}

![Catalase-integrated hyaluronic acid for enhanced PDT. **A.** Schematic illustration of the processes after intravenous injection of HA-CAT\@aCe6 nanoplatforms into tumor-bearing mice. **B.** Relative tumor volumes of MDA-MB-231 tumor bearing mice with five treatment groups over 14 days. **C.** Photos of excised tumors from mice on the 14^th^ day after these treatments. Adapted with permission from ref. [@B163]. Copyright 2019 American Chemical Society.](thnov10p7287g008){#F8}

![Hydrangea-structured nanoplatforms for tumor imaging and therapy.**A.** Schematic illustration of the fabrication of MDSP NPs. **B.** MDSP NPs for tumor microenvironment responsive chemo/photodynamic/photothermal therapy under xenon lamp irradiation. Adapted with permission from ref. [@B175]. Copyright 2019 Elsevier.](thnov10p7287g009){#F9}

![MnFe~2~O~4~\@metal-organic frameworks for enhanced PDT. **A.** Schematic illustration of the synthesis process of MnFe~2~O~4~\@MOF core-shell nanostructure. **B.** *In vivo T*~1~-weighted MR images of mice at 24 h post injection of PBS or MnFe~2~O~4~\@MOF-PEG. **C.** Tumor growth curves of each group post-intratumoral administration under laser irradiation. Adapted with permission from ref. [@B179]. Copyright 2019 Wiley-VCH.](thnov10p7287g010){#F10}

![MnO~2~ nanodots-anchored nanoplatforms for chemo-PDT. **A.** Schematic illustration of the fabrication of FMZ/DC nanoplatforms with oxygen generation enhancing the chemo-photodynamic therapy. **B.** Tumor growth curves of different groups of 4T1 tumor-bearing mice. **C.** Images of tumors collected from different groups of mice 14 day after different treatment. Adapted with permission from ref. [@B181]. Copyright 2018 Wiley-VCH.](thnov10p7287g011){#F11}

![Nanozyme decorated MOF for enhanced PDT. **A.** Schematic illustration of the preparation process of PCN-224-Pt. **B.** Representative photographs of the tumor dissection. **C.** Relative tumor volume after various treatments indicated. Adapted with permission from ref. [@B185]. Copyright 2018 American Chemical Society.](thnov10p7287g012){#F12}

![**A.** Structure of PCCN and schematic diagram of 630 nm light-driven water splitting enhanced PDT. **B.** *In vivo* fluorescence imaging of PCCN at different time points after intravenous injection. **C.** Tumor images at the 12^th^ day post-treatment. **D.** Relative tumor volume post-treatment, the intravenous injection of samples was performed on different days. Adapted with permission from ref. [@B199]. Copyright 2016 American Chemical Society.](thnov10p7287g013){#F13}

![Illustration showing the preparation process and mechanisms underlying the effects of X-PDT with LiLuF~4~:Ce\@SiO~2~\@Ag~3~PO~4~\@Pt(IV) nanoparticles (LAPNP). Adapted with permission from ref. [@B218]. Copyright 2018 American Chemical Society.](thnov10p7287g014){#F14}

![NIR photosensitized nanoparticles for enhanced PDT. **A.** Schematic illustration of RET-photosensitizer-mediated PDT. **B.** Specific targeted NIR-fluorescence tumor imaging *in vivo.***C.** Tumor growth inhibition by RET-BDP-TNM-mediated PDT in 4T1 tumors. **D.** Digital photos of tumors for the four groups of mice. Adapted with permission from ref. [@B234]. Copyright 2017 Wiley-VCH.](thnov10p7287g015){#F15}

###### 

Targeting and responsive nanoplatforms for enhanced PDT

  Nanoplatforms design                 PS                     Enhanced mechanism                      Improved therapeutics   Ref
  ------------------------------------ ---------------------- --------------------------------------- ----------------------- -----
  Chimeric peptide                     Ce6                    Cell membrane target                    PDT                     53
  Peptide                              PpIX                   pH-driven membrane-anchoring            PDT                     54
  SiO~2~-TAT/RGD                       Ce6                    Nuclear-targeted delivery               PDT                     56
  Coordination polymers                Ce6                    Nuclear-targeted drug delivery          PDT                     57
  Supramolecular nanocarriers          Ce6                    Mitochondria-target                     PDT                     62
  Chimeric peptide                     PpIX                   Mitochondria/plasma membrane-target     PDT                     63
  Lyso-Ru-NO\@FA\@C-TiO~2~             C-TiO~2~               Lysosome-targeted delivery              PDT                     66
  Iridium(III) complexes               Ir-P(ph)~3~/Ir-alkyl   Mitochondria /lysosome target           PDT                     67
  C-Phycocyanin-ZnPc conjugates        ZnPc                   Macrophage-target                       PDT                     69
  Pseudopolyrotaxane micelles          PpIX                   pH-responsive release                   PDT                     88
  Polymeric micelles                   Ce6                    pH-responsive/EGFR targeting peptides   PDT                     89
  Coordination polymer nanoparticles   ZnPc                   Charge-reversal                         PDT                     92
  Supramolecular amphiphiles           Ce6                    Redox-responsive                        PDT                     101
  Amphiphilic polymers                 Ce6                    Redox stimulation                       PDT                     102
  Nano-MOF with Cu^II^                 Porphyrin              Reducing of GSH                         PDT                     105
  BSA-MBPB                             Methylene blue         H~2~O~2~-activatablity                  PDT                     106
  HA-Ce6 conjugation                   Ce6                    Hyaluronidase                           PDT                     109
  Polymer vesicles                     Nile blue              Enzyme simulation                       PDT                     111
  Amphiphilic block copolymer          Ce6                    Singlet oxygen-sensitive                Chemo-PDT               117
  Polymeric micelles                   Ce6                    Hypoxia/Singlet oxygen responsive       PDT                     118
  Dopamine-reduced graphene oxide      Ce6                    Photothermal responsive                 PDT/PTT                 133

###### 

Chemical effects of nanoplatforms for enhanced PDT

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Nanoplatforms design                                   PS                         Enhanced mechanism                                     Improved therapeutics   Ref
  ------------------------------------------------------ -------------------------- ------------------------------------------------------ ----------------------- -----
  Perfluorotributylamine-HSA                             IR780                      Perfluorotributylamine affinity O~2~                   PDT                     146

  Perfluorohexane \@Ce6\@O~2~ nanodroplets               Ce6                        Perfluorohexane\                                       PDT                     147
                                                                                    affinity O~2~                                                                  

  Covalent organic polymers with PFC                     Porphyrin                  Perfluoro-15-crown-\                                   PDT                     148
                                                                                    5-ether affinity O~2~                                                          

  Fluorocarbon-functionalized nanoparticles              IR780                      pH-sensitive fluorocarbon/ iRGD                        PDT                     149

  Lipid-polymer/PFC                                      Ce6                        Perfluoro-octan-1-ol affinity O~2~                     PDT                     150

  Upconversion nanoparticles with RBC                    Rose bengal                RBC deliver O~2~                                       PDT                     151

  RBC/ammonium bicarbonate/DOX                           ICG                        RBC deliver O~2~                                       Chem/\                  152
                                                                                                                                           PTT\                    
                                                                                                                                           /PDT                    

  Amphiphilic triblock copolymers                        ZnPc                       Hemoglobin deliver O~2~                                PDT                     153

  Hemoglobin conjugated polymer nanoparticles            Luminol                    Hemoglobin deliver O~2~                                PDT                     154

  Catalase-loaded hierarchical zeolite                   Methylene blue             Catalase generate O~2~                                 PDT                     155

  HSA-Ce6-catalase-PTX nanoparticles                     Ce6                        Catalase generate O~2~                                 Chemo-PDT               157

  PTX/ICG-nanovehicles\@Au@ catalase nanoparticles       ICG                        Catalase generate O~2~                                 PDT/PTT                 159

  UCNPs \@ZIF-8\@catalase                                Methylene blue             Catalase generate O~2~                                 PDT                     160

  Catalase\@S/Ce6-CTPP/DPEG                              Ce6                        Catalase generate O~2~                                 Immuno-PDT              161

  Catalase-entrapped nanocapsules                        Porphyrin                  Catalase generate O~2~                                 PDT                     162

  Catalase-integrated hyaluronic acid                    Ce6                        Catalase generate O~2~                                 PDT                     163

  Black phosphorus/MnO~2~                                Black phosphorus           MnO~2~ generate O~2~                                   PDT                     164

  Magnetofluorescent Carbon Dot                          Phthalocyanine             MnO~2~ nanodots\                                       PDT                     167
                                                                                    generate O~2~                                                                  

  Mn-Cdots/DOX-loaded mesoporous\                        Phthalocyanine             MnO~2~ nanodots\                                       PDT/PTT                 168
  silica-coated gold cube nanocomposites                                            generate O~2~                                                                  

  PLGA/hematoporphyrin monomethyl ether \@MnO~2~         Porphyrin                  MnO~2~ generate O~2~                                   PDT                     169

  Upconversion composite nanoparticles                   Ce6                        MnO~2~ generate O~2~                                   PDT                     170

  Ce6\@MnO~2~-PEG nanoparticles                          Ce6                        MnO~2~ generate O~2~                                   PDT                     167

  Hydrangea MnO~2~/DOX                                   aza-BODIPY                 MnO~2~ generate O~2~                                   PDT                     175

  Semiconducting hybrid nanoparticles                    PCPDTBT                    MnO~2~ generate O~2~                                   PDT                     176

  MnFe~2~O~4~-anchored mesoporous silica                 Ce6                        Fenton reaction                                        PDT                     178

  MnFe~2~O~4~\@Metal-organic\                            Porphyrin                  Fenton reaction/\                                      PDT                     179
  frameworks                                                                        consume GSH                                                                    

  MoS~2~/rGO-MnO~2~-PEG                                  Reduced graphene oxide     p-n\                                                   PDT                     180
                                                                                    heterojunction/ MnO~2~ generate O~2~                                           

  F127-MnO~2~-ZIF\@DOX/C~3~N~4~                          C~3~N~4~                   MnO~2~ nanodots\                                       Chemo-PDT               181
                                                                                    generate O~2~                                                                  

  Pt Metal-organic frameworks                            Porphyrin                  Pt nanozymes\                                          PDT                     185
                                                                                    produce O~2~                                                                   

  Pd\@Pt-PEG-Ce6                                         Ce6                        Pt nanozymes\                                          PDT/PTT                 186
                                                                                    produce O~2~                                                                   

  H~2~O~2~/PLGA                                          IR780                      H~2~O~2~ release O~2~                                  PDT                     187

  UCNP\@mSiO~2~\@ZIF-90-DOX-PEGFA                        Rose bengal                ZIF-90\                                                Chemo-PDT               188
                                                                                    reserve O~2~                                                                   

  UCNP with hyperbaric oxygen                            Rose bengal                Hyperbaric oxygen\                                     PDT                     189
                                                                                    supply O~2~                                                                    

  Carbon dots/TiO~2~ nanotubes                           Carbon dots                Carbon dots enhance light absorption                   PDT                     195

  TiO~2~-ruthenium nano-photosensitizer                  Organometallic ruthenium   N~3~ injected electrons into TiO~2~                    PDT                     196

  Carbon-dot-doped C~3~N~4~/ amphipathic polymer         PpIX                       C~3~N~4~ split water to generate O~2~                  PDT                     199

  Fe^III^-doped-C~3~N~4~ nanofusiform                    Methylene blue             H~2~O~2~-activatable, O~2~-evolving, mitochondrial-\   PDT                     200
                                                                                    target                                                                         

  Cu^II^-doped-C~3~N~4~                                  C~3~N~4~                   Reduce GSH                                             PDT                     201

  Ultrathin Graphdiyne oxide/iRGD peptide-modified RBC   Graphdiyne oxide           sufficient O~2~/ tumor cell targeting /penetrating     PDT/PTT                 202
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Physical effects of nanoplatforms for enhanced PDT

  Nanoplatforms design                           PS                 Enhanced mechanism                 Improved therapeutics   Ref
  ---------------------------------------------- ------------------ ---------------------------------- ----------------------- -----
  Ion-incorporated silicate nanoscintillators    Rose bengal        X-rays transmit the energy to PS   PDT                     213
  Mesoporous LaF~3~:Tb nanoparticles             Rose bengal        X-rays transmit the energy to PS   PDT                     216
  LiLuF~4~:Ce\@SiO~2~\@Ag~3~PO~4~\@Pt(IV)        LiLuF~4~:Ce        X-rays transmit the energy to PS   PDT                     218
  CeF~3~:Gd^3+^,Tb^3+^\@SiO~2~                   Rose bengal        X-rays transmit the energy to PS   PDT/ radiotherapy       219
  Gold nanorods@ SiO~2~                          (Eu) complexes     X-rays transmit the energy to PS   PDT/PTT                 220
  PLGA /Gold nanoparticles                       Verteporfin        X-rays transmit the energy to PS   PDT                     222
  Silica-gold nanorod                            ICG                SPR                                PDT                     225
  UCNP-gold nanorod                              Methylene blue     SPR                                PDT                     226
  Gold nanoparticles with black phosphorus       Black phosphorus   SPR                                PDT/PTT                 227
  Multilayered upconversion                      PFSBT              Resonance energy transfer          PDT                     232
  SnWO~4~-based nanohybrids                      SnWO~4~            Resonance energy transfer          PDT/ radiotherapy       233
  Dyad molecule with pluronic F-127-folic acid   BODIPY             Resonance energy transfer          PDT                     234
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